Glycemic Control During the Menstrual Cycle in Women With Type 1 Diabetes: Performance of an Automated Insulin
Tatiana Rojas López1, Daniel Lozano Acosta1, Beatriz Barquiel Alcalá1
1Department of Endocrinology, Hospital Universitario La Paz, Madrid, Spain.
Introduction:
Scientific evidence on the impact of the female hormonal cycle on glycemic control in type 1 diabetes (T1D) remains limited. This study aimed to evaluate variations in glycemic control and insulin requirements throughout the menstrual cycle in women with T1D using an automated insulin delivery (AID) system.
Materials And Methods:
An observational cohort study was conducted in women with T1D using the MiniMed 780G AID system. Continuous glucose monitoring (CGM) and insulin delivery data were analysed and compared between the late luteal phase (LLP) (Days -7 to -1) and the early follicular phase (EFP) (Days 1-7) across up to three cycles per participant.
Results:
A total of 48 cycles from 17 women were analysed (mean age 39.9 ± 6.3 years; diabetes duration 30.1 ± 9.7 years; BMI 25.7 ± 3.6 kg/m2). During the LLP, participants showed a lower percentage of time in range (%TIR: 80.7% vs. 82.7%, p < 0.05) and higher time above range (%TAR: 17.3% vs. 14.6%, p < 0.01) and mean glucose (141 vs. 135 mg/dL, p < 0.01). In contrast, % time below range (%TBR) was higher during the EFP (2.8% vs. 2.0%, p < 0.01). The total daily insulin dose (TDD) increased during the LLP (33.1 vs. 32.0 units, p < 0.05), mainly due to higher prandial insulin (19.5 vs. 18.6 units), without significant differences in basal or autocorrection doses.
Conclusions:
Women with T1D using an AID system demonstrated phase-dependent differences in glycemic control, with lower time in range and greater hyperglycemia during the LLP and a higher susceptibility to hypoglycemia during the early follicular phase, accompanied by higher prandial insulin requirements.
More Related Videos
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
09:44Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
